D-1043-2018 Class II Terminated

Recalled by PharMEDium Services, LLC — Dayton, NJ

FDA drug recall D-1043-2018 was initiated by PharMEDium Services, LLC on Jul 24, 2018 and is designated Class II. Reason for recall: CGMP deviations: Product was released while a hood certification discrepancy was being investigated. The recall status is terminated (terminated Dec 10, 2018). Affected quantity: 230 Intravia Bags.

Recall Details

Product Type
Drugs
Report Date
Aug 15, 2018
Initiation Date
Jul 24, 2018
Termination Date
Dec 10, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
230 Intravia Bags

Product Description

10 mcg/mL Fentanyl Citrate (Preservative Free) in 0.9% Sodium Chloride 250 mL in 250 mL Intravia Bag and 10 mcg/mL Fentanyl Citrate (Preservative Free) in 0.9% Sodium Chloride 100 mL in 150 mL Intravia Bag, PharMEDium Services, LLC.

Reason for Recall

CGMP deviations: Product was released while a hood certification discrepancy was being investigated.

Distribution Pattern

Product was distributed throughout the United States

Code Information

Lot 181760013D, 181730007D, Exp 08/09/2018, 09/02/2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1043-2018
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 25, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.